Eiger BioPharmaceuticals, Inc.
11
Stacey G Jernigan
04/01/2024
03/27/2025
Yes
v
| SEALEDEXH, SealedDocument, REFORM, COMPLEX, jntadmn, LEAD, ClaimsAgent, EXHIBITS |
Assigned to: Chief Bankruptcy Jud Stacey G Jernigan Chapter 11 Voluntary Asset |
|
Debtor Eiger BioPharmaceuticals, Inc.
c/o Douglas Staut, CRO 2100 Ross Avenue Dallas, TX 75201 SANTA CLARA-CA Tax ID / EIN: 33-0971591 |
represented by |
Thomas Robert Califano
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-5575 Fax : 212-839-5599 Email: tom.califano@sidley.com Veronica A. Courtney
Sidley Austin LLP 1000 Louisiana Street Ste 5900 Houston, TX 77002 713-495-4572 Fax : 713-495-7799 Email: vcourtney@sidley.com William E Curtin
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-6745 Fax : 212-839-5599 Email: wcurtin@sidley.com Nathan Elner
Sidley Austin LLP 2021 McKinney Avenue Suite 2000 Dallas, TX 75201 212-839-5300 Email: nelner@sidley.com John Joseph Kuster
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-7336 Email: jkuster@sidley.com Jon Muenz
Sidley Austin LLP 787 7th Avenue New York, NY 10019 212-839-5901 Fax : 212-839-5599 Email: jmuenz@sidley.com Patrick J. Neligan, Jr.
Neligan LLP 4851 LBJ Freeway Suite 700 Dallas, TX 75244 214-912-9861 Email: pneligan@neliganlaw.com Charles Martin Persons, Jr.
Sidley Austin LLP 2020 McKinney Avenue, Suite 2000 Dallas, TX 75210 (214) 981-3300 Fax : (214) 981-3400 Email: charlespersons@paulhastings.com TERMINATED: 09/24/2024 Andrew J. Townsell
Sidley Austin LLP 787 7th Avenue New York, NY 10019 212-839-6793 Email: andrew.townsell@sidley.com Anne G. Wallice
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 212-839-6021 Email: anne.wallice@sidley.com |
U.S. Trustee United States Trustee
1100 Commerce Street Room 976 Dallas, TX 75202 214-767-8967 |
represented by |
Elizabeth Ziegler Young
U.S. Trustee Office 1100 Commerce Street, Room 976 Dallas, TX 75242 (214) 767-8967 Fax : (214) 767-8971 Email: elizabeth.a.young@usdoj.gov |
Creditor Committee Official Unsecured Creditors Committee
Munsch Hardt Kopf & Harr, P.C. 500 N. Akard Street Suite 4000 Dallas, TX 75201 214-855-7500 |
represented by |
Shira A. Baratz
Meland Budwick, P.A. 200 S. Biscayne Blvd., Suite 3200 MIami, FL 33131 305-358-6363 Fax : 305-358-1221 Email: sbarttz@melandbudwick.com Thomas Daniel Berghman
Munsch Hardt Kopf & Harr PC 500 N Akard Street, Suite 3800 Dallas, TX 75201-6659 (214) 855-7554 Fax : (214) 978-4346 Email: tberghman@munsch.com Michael S. Budwick
Meland Budwick, P.A. 200 S. Biscayne Blvd., Suite 3200 MIami, FL 33131 305-358-6363 Fax : 305-358-1221 Email: mbudwick@melandbudwick.com Daniel N. Gonzalez
Meland Budwick, PA 200 S. Biscayne Boulevard, Suite 3200 Miami, FL 33131 (305) 358-6363 Fax : (305) 358-1221 Email: dgonzalez@melandbudwick.com Meaghan E. Murphy
Meland Budwick, P.A. 200 S. Biscayne Blvd., Suite 3200 MIami, FL 33131 305-358-6363 Fax : 305-358-1221 Email: mmurphy@melandbudwick.com Garrick Chase Smith
Munsch Hardt Kopf & Harr, P.C. 500 N. Akard Street Suite 4000 Dallas, TX 75201 214-740-5110 Fax : 214-855-7584 Email: gsmith@munsch.com |
| Date Filed | # | Docket Text |
|---|---|---|
| 03/27/2025 | 795 | Declaration re: Declaration of James Vollins in Support of the Liquidating Trustee and the Plan Administrator's Limited Response to Motion of Sentynl Therapeutics, Inc. to (I) Enforce the Zokinvy Sale Order and (II) for Contempt Against Eiger InnoTherapeutics, Inc. filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (RE: related document(s)[794] Response). (Venus, S.) |
| 03/27/2025 | 794 | Response opposed to (related document(s): [779] Motion for contempt against Eiger InnoTherapeutics, Inc. (n/k/a EIT Pharma, Inc.) regarding the Zokinvy Sale OrderSentynl Therapeutics, Inc.'s Motion (I) to Enforce the Zokinvy Sale Order and (II) For Contempt Against Eiger Innotherapeutics, In filed by Interested Party Sentynl Therapeutics, Inc., [781] Motion to enforceSentynl Therapeutics, Inc.'s Motion (I) to Enforce the Zokinvy Sale Order and (II) For Contempt Against Eiger Innotherapeutics, Inc. (related document(s): [162] Order (generic)) filed by Interested Party Sentynl Therapeutics, Inc.) filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee. (Venus, S.) |
| 03/27/2025 | 793 | SEALED document regarding: Limited Response of the Liquidating Trustee and Plan Administrator to Motion of Sentynl Therapeutics, Inc. to (I) Enforce the Zokinvy Sale Order and (II) for Contempt Against Eiger InnoTherapeutics, Inc. per court order filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (RE: related document(s)[783] Order on motion to seal). (Venus, S.) |
| 03/26/2025 | 792 | Notice of hearing on EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.'s Motion to Confirm Terms of Lonafarnib/Lambda Sale Order filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc. (RE: related document(s)[787] Emergency Motion to enforce EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.'s Emergency Motion to Confirm Terms of Lonafarnib/Lambda Sale Order (related document(s): [558] Order on motion to sell) Filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.). Hearing to be held on 4/15/2025 at 09:30 AM at https://us-courts.webex.com/meet/jerniga for [787], (Brookner, Jason) |
| 03/26/2025 | 791 | Notice of Appearance and Request for Notice by Mark Stromberg filed by Interested Party Sentynl Therapeutics, Inc.. (Stromberg, Mark) |
| 03/25/2025 | 790 | Response opposed to (related document(s): [787] Emergency Motion to enforce EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.'s Emergency Motion to Confirm Terms of Lonafarnib/Lambda Sale Order (related document(s): [558] Order on motion to sell) filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.) filed by Interested Party Sentynl Therapeutics, Inc.. (Attachments: # (1) Exhibit A # (2) Exhibit B # (3) Exhibit C # (4) Exhibit D) (Ray, Hugh) |
| 03/24/2025 | 787 | Emergency Motion to enforce EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc.'s Emergency Motion to Confirm Terms of Lonafarnib/Lambda Sale Order (related document(s): [558] Order on motion to sell) Filed by Interested Party EIT Pharma, Inc., formerly known as Eiger InnoTherapeutics, Inc. (Brookner, Jason) |
| 03/21/2025 | 786 | Notice of hearing for April 15, 2025 Setting filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (RE: related document(s)[771] Objection to claim(s) of Creditor(s) Merck Sharp and Dohme LLC.. Filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee. Responses due by 3/26/2025. (Attachments: # 1 Proposed Order) (Venus, S.), [774] SEALED document regarding: The Liquidating Trustee's and Plan Administrator's Objection to Claim Nos. 83 and 43 Filed by Merck Sharp and Dohme LLC per court order filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (RE: related document(s)[773] Order on motion to seal). (Attachments: # 1 Proposed Order) (Venus, S.), [777] Objection to (related document(s): [729] Application for administrative expenses Motion for Allowance of Administrative Expense Claim of Sentynl Therapeutics, Inc. filed by Interested Party Sentynl Therapeutics, Inc.)Objection and Response of the Liquidating Trustee and Plan Administrator to Motion for Allowance of Administrative Expense Claim of Sentynl Therapeutics, Inc. filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee. (Attachments: # 1 Proposed Order) (Venus, S.), [779] Motion for contempt against Eiger InnoTherapeutics, Inc. (n/k/a EIT Pharma, Inc.) regarding the Zokinvy Sale OrderSentynl Therapeutics, Inc.'s Motion (I) to Enforce the Zokinvy Sale Order and (II) For Contempt Against Eiger Innotherapeutics, Inc. Filed by Interested Party Sentynl Therapeutics, Inc. (Attachments: # 1 Exhibit A Proposed Order), [781] Motion to enforceSentynl Therapeutics, Inc.'s Motion (I) to Enforce the Zokinvy Sale Order and (II) For Contempt Against Eiger Innotherapeutics, Inc. (related document(s): [162] Order (generic)) Filed by Interested Party Sentynl Therapeutics, Inc. (Attachments: # 1 Exhibit A Proposed Order), [784] SEALED document regarding: Objection and Response of the Liquidating Trustee and Plan Administrator to Motion for Allowance of Administrative Expense Claim of Sentynl Therapeutics, Inc. per court order filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (RE: related document(s)[783] Order on motion to seal). (Attachments: # 1 Proposed Order) (Venus, S.)). Hearing to be held on 4/15/2025 at 09:30 AM at https://us-courts.webex.com/meet/jerniga for [771] and for [781] and for [779] and for [784] and for [774] and for [777], (Venus, S.) |
| 03/10/2025 | 785 | SEALED document regarding: Declaration of Joshua Nahas in Support of Objection and Response of the Liquidating Trustee and Plan Administrator to Motion for Allowance of Administrative Expense Claim of Sentynl Therapeutics, Inc. per court order filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (RE: related document(s)[783] Order on motion to seal). (Attachments: # (1) Exhibit A # (2) Exhibit B # (3) Exhibit C # (4) Exhibit D # (5) Exhibit E # (6) Exhibit F # (7) Exhibit G # (8) Exhibit H # (9) Exhibit I) (Venus, S.) |
| 03/10/2025 | 784 | SEALED document regarding: Objection and Response of the Liquidating Trustee and Plan Administrator to Motion for Allowance of Administrative Expense Claim of Sentynl Therapeutics, Inc. per court order filed by Interested Party Dundon Advisers, LLC, as Eiger Liquidating Trustee (RE: related document(s)[783] Order on motion to seal). (Attachments: # (1) Proposed Order) (Venus, S.) |